MalarVx Analysis: $2M Raised
What is MalarVx?
A malaria vaccine company with a new approach
Location
Seattle, United States
Employees
1-10
Founded
2012
Product Features & Capabilities
- Vaccine development
- In vitro mosquito-stages research
- Clinical trials pipeline
- Scientific publications
